Nudges for Smoking Cessation in Mental Illness (ISRAISE Trial)

N/A

Waitlist Available

Led By Li-Shiun Chen, M.D., MPH, ScD

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months, 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will study the effectiveness of a multi-level intervention to help people with serious mental illness quit smoking.

Who is the study for?

This trial is for adults over 18 who are patients at a participating clinic, speak and understand English, and currently smoke more than five cigarettes per day. It's not for those actively using or prescribed smoking cessation medication in the past month.

What is being tested?

'Nudges to Quit' is being tested as a way to help people with serious mental illness quit smoking by increasing engagement between patients, case workers, and pharmacists. This pilot study will inform a larger future trial.

What are the potential side effects?

Since 'Nudges to Quit' involves behavioral strategies rather than medications, there may be no direct medical side effects; however, participants might experience stress or anxiety related to quitting smoking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Abstinence outcomes across multiple time points

Proportion of patients receiving any tobacco treatment

Quit attempts

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: "Nudges to Quit"Experimental Treatment1 Intervention

Patients will receive a multilevel intervention that includes reminders to care team to increase tobacco treatment engagement.

Group II: Usual CareActive Control1 Intervention

Patients will receive general brief advice about smoking cessation at patient tobacco treatment needs assessment then receive the intervention at 3 months.

Do I qualify?Apply below to find out